Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel small molecule precision cancer therapies, ...

Ovarian cancer is one of the most serious cancers that affect women. It is known for being difficult to detect early and ...

ANN ARBOR, Michigan — A new study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments. High-grade serous carcinoma, ...

Most uterine cancers have excellent five-year survival rates – up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...

Effect of chemotherapy treatment on immunotherapy efficacy in colorectal cancer (CRC) patients with high microsatellite instability (MSI-H) and/or tumor mutational burden (TMB-H). This is an ASCO ...

Scientists have made an important discovery about one of the most dangerous forms of ovarian cancer, offering new hope for ...

Mapping the burden of uterine cancer in the EU from 1990-2021: Global and national disparities, age trends, and implications for public health.